Joy Falkenburg
Family Medicine · Custer, SDNPI 1295789873
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $749 and has fallen 65.8% since, to $256 in 2025. Among family medicine clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$508
- AbbVie$349
- AstraZeneca$208
- Amgen$201
- Bayer$184
- Pfizer$158
- plus $1K from 13 others
What the payments were for
- Food & beverage$2,599100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $508 |
| AbbVie(2 entities) | 13 | $349 |
| AstraZeneca | 4 | $208 |
| Amgen | 13 | $201 |
| Bayer | 6 | $184 |
| Pfizer | 10 | $158 |
| Lilly USA, LLC | 10 | $157 |
| Sanofi-aventis U.S. LLC | 3 | $157 |
| Boehringer Ingelheim | 9 | $143 |
| GSK | 10 | $137 |
| E.r. Squibb & Sons, L.L.C. | 7 | $109 |
| Merck | 6 | $89 |
| Novartis | 4 | $64 |
| Exact Sciences | 3 | $43 |
| Johnson & Johnson | 2 | $36 |
| Grifols USA, LLC | 1 | $25 |
| Vertex | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$125
- Kerendia$125
- FASENRA$116
How this compares
$2,611 in reported general payments places this provider in the 90th percentile of 408 family medicine providers in South Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $54,858 |
| Dupixent PenDupilumab | 12 | $45,876 |
| EliquisApixaban | 42 | $45,534 |
| JardianceEmpagliflozin | 27 | $38,978 |
| EntrestoSacubitril/Valsartan | 29 | $28,795 |
| OzempicSemaglutide | 15 | $25,529 |
| MounjaroTirzepatide | 20 | $21,685 |
| Bydureon BciseExenatide Microspheres | 21 | $17,527 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 18 | $5,694 |
| SynthroidLevothyroxine Sodium | 100 | $5,334 |
| ZenpepLipase/Protease/Amylase | 18 | $4,682 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 20 | $4,502 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $3,758 |
| Losartan Potassium | 275 | $3,092 |
| Atorvastatin Calcium | 300 | $2,570 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Shingrix, Incruse Ellipta | $137 | $63,11886 claims |
| PfizerEliquis, Abrysvo | $158 | $51,22860 claims |
| Boehringer IngelheimJardiance | $143 | $38,97827 claims |
| NovartisEntresto | $64 | $28,79529 claims |
| Novo NordiskOzempic | $508 | $25,52915 claims |
| Lilly USA, LLCMounjaro | $157 | $21,68520 claims |
| AbbVieSynthroid | $349 | $5,334100 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 408 family medicine providers in South Dakota.
Other family medicine in Custer
- Terry GraberCuster$6K
- Brandyn TarapCuster$3K
- Monaleze SainiCuster$2K
- Lisa BrownCuster$2K
- Louise HalbleibCuster$1K
- Kyla Helm-SwansonRapid City$22K
- Andrew BurchettSioux Falls$13K
- Lornell HansenSioux Falls$11K
- Michael GerlachMitchell$9K
- Jeffry MeyerSioux Falls$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.